Conference Partner


AstraZenecahas a deep-rooted heritage in oncology and offers a quickly growing portfolio of medicines with the potential to transform patients' lives. By following the science and championing the development of personalised combinations, AstraZeneca is working to redefine cancer treatment and one day eliminate cancer as a cause of death.

This information is intended for healthcare professionals only. Any compounds illustrated from AstraZeneca refer to selected pipeline products still under development. AstraZeneca pipeline products are investigational products and, as such, are not approved by the US Food and Drug Administration, European Medicines Agency, or any other regulatory agency for the uses under investigation. Information regarding these investigational products should under no circumstances be regarded as a recommendation for their use or of their safety or efficacy.

Contact details

Documents & Links